Observational studyCardiovascular diabetology2025
Favorable outcomes of SGLT2 inhibitor use in pacemaker recipients: a population-based study.
Yuval Avidan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it